Purpose There is an increasing demand for researchers to provide research results to
participants. Our aim was to define an appropriate process for this, based on needs and …

BACKGROUND: Low rates of participation of adolescents and young adults (AYAs) in
clinical oncology trials may contribute to poorer outcomes. Factors that influence the …

OBJECTIVE: To determine current practices in neonatal intensive care units (NICUs) of
managing postoperative pain, pain associated with nonsurgical procedures and disease …

Complementary and alternative medicine (CAM) is used by some patients to supplement
their health care. Information on the use of CAM in children who are not chronically ill is …

BACKGROUND Researchers have a moral responsibility to offer to return research results to
participants, but the needs and attitudes of parents and adolescents with cancer in …

Methemoglobinaemia is a rare cause of cyanosis in newborns. Congenital
methemoglobinaemias due to M haemoglobin or deficiency of cytochrome b5 reductase are …

10009 Background: In National Wilms Tumor Study-5, tumor-specific combined loss of
heterozygosity (LOH) of chromosomes 1p and 16q was associated with adverse outcome in …

Involvement of the falx cerebri in infants with stage 4 neuroblastoma is thought to be rare.
The falx is derived from the neural crest and thus may be a location for primary …

10516 Background: Although renal cell carcinoma (RCC) is the second most common
pediatric kidney cancer, no previous prospective clinical trials have been conducted …

10000 Background: The Children's Oncology Group (COG) Renal Tumor (RT) Biology and
Risk Stratification Protocol incorporates real-time central review to direct risk stratification …